Steven Cohen Icosavax, Inc. Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$7.22 - $10.05 $8,664 - $12,060	-1,200 Reduced 0.96%	123,200 $954,000
Q2 2023 Aug 14, 2023	BUY	$4.89 - $10.57 $606,927 - $1.31 Million	124,116 Added 43702.82%	124,400 $1.24 Million
Q1 2023 May 15, 2023	BUY	$5.62 - $11.51 $1,596 - $3,268	284 New	284 $1,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.